Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis
- 1 March 1992
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 120 (3) , 468-473
- https://doi.org/10.1016/s0022-3476(05)80923-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritisThe Journal of Pediatrics, 1990
- Low-dose methotrexate treatment of rheumatoid arthritis; Long-term observation of efficacy and safetyClinical Rheumatology, 1989
- Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritisArthritis & Rheumatism, 1989
- Advanced drug therapy for juvenile rheumatoid arthritisThe Journal of Pediatrics, 1989
- Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritisArthritis & Rheumatism, 1988
- Methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritisArthritis & Rheumatism, 1986
- Adverse Histopathologic Effects of Chemotherapeutic Agents in Childhood Leukemia and LymphomaPediatric Pathology, 1984
- Methotrexate guidelines—revisedJournal of the American Academy of Dermatology, 1982